SHAKAIB U

Quest Diagnostics 2002 to present Co-Investigator, (0.01%) ($50,000) (PI: Jan Basile, MD) ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) trial. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download